Please note that Internet Explorer version 8.x is not supported as of January 1, 2016. Please refer to this support page for more information.
The people in modern societies have found to be more lonely due to longer life span, rising single-person household, and disconnected interpersonal networks. Recently has research begun to shed light on how this phenomenon influences consumers’ compensatory consumption to cope with negative moods caused by loneliness. The hospitality and tourism industries need a better understanding of the ways in which their products and services (e.g. dining-out, traveling, and drinking alcohol) provide opportunities for consumers to cope with such loneliness. Thus, this study explored the benefits of hospitality and tourism experiences for individuals who dine out, travel, and drink as a means of coping with feelings of loneliness. Hence, the goals of the current study are threefold: (1) to examine if loneliness influences consumers to engage in consumption in order to cope with their feelings, (2) to compare age-related differences in coping strategies related to loneliness, and (3) to investigate the therapeutic benefits of dining out, traveling, and drinking across loneliness levels. The results of this study suggest that traveling and dining-out can provide significant ‘therapeutic benefits’ by repairing feelings of loneliness.
Add to Mendeley
A therapeutic benefit is a benefit or effect obtained as a result of treatment. The term therapeutic defines any action or method used for the treatment of diseases or disorders. Thus, a therapeutic benefit is a positive result that occurs as a result of a method used to treat a disease or disorder.
A treatment may be of therapeutic benefit whether or not it is classified as a medical or insured treatment. In fact, many therapeutic measures may not be covered by an individual's health insurance plan yet still have a positive effect on the individual's well-being. Creating art, indulging in self-care, and other meditative activities are often considered to be therapeutic.
WorkplaceTesting Explains Therapeutic Benefit
Therapeutic benefits may sometimes be referred to as therapeutic effects.
The definition of therapeutic benefit encompasses traditional western medical treatments as well as other non-traditional remedies. A treatment may be considered to have therapeutic benefit if it enhances an individual's physical or mental well-being.
It may sometimes be important to categorize a specific therapeutic method of treatment as a medical treatment or not in order to comply with federal workplace recording laws. For example, a therapeutic exercise or physical therapy provided on the worksite to address a workplace injury may be considered medical treatment under the Occupational Safety and Health Administration's recordkeeping guidelines.
Clinical research regarding the therapeutic benefits of cannabis (“marijuana”) has been almost non-existent in the United States since cannabis was given Schedule I status in the Controlled Substances Act of 1970. In order to discover the benefits and adverse effects perceived by medical cannabis patients, especially with regards to chronic pain, we hand-delivered surveys to one hundred consecutive patients who were returning for yearly re-certification for medical cannabis use in Hawai‘i.
While the relative safety of cannabis as medication is easily established, the degree of efficacy is still being established. The reported pain relief by patients in this survey is enormous. One reason for this is that patients were already self-selected for success: they had already tried cannabis and found that it worked for them. For this sample, the benefits of cannabis outweighed any negative effects. The study design may therefore lend itself to over-estimating the benefits and under-estimating the negative side-effects if extrapolated to the general population.
While opioids are generally considered to have little benefit in chronic neuropathic pain, several RCT’s have shown that cannabinoids can relieve general neuropathic pain, 16 as well as neuropathic pain associated with HIV and with multiple sclerosis (MS). 17 , 18 One study found that cannabis had continuing efficacy at the same dose for at least two years. 19
So why is cannabis still held hostage by the DEA as a Schedule I substance? On June 18, 2010, the Hawai‘i Medical Association passed a resolution stating in part that:
Between July of 2010 and February of 2011, we hand-delivered questionnaires to one hundred consecutive patients who had been certified for the medical use of cannabis for a minimum of one year and were currently re-applying for certification.